We investigated the effect of the known an tagonist of platelet-activating factor (PAF), ginkgolide B, on postischemic neuronal damage in the rat. Neuronal necroses were evaluated in the hippocampus 7 days after a IO-min forebrain ischemia. Preischemic application of
Ginkgolide B, a component of an extract of Ginkgo hi/aha leaves (Drieu, 1986) , has been shown to be a potent antagonist of platelet-activating fac tor (PAF) (Braquet et al., 1985) . A reduction of postischemic neurological disturbances and brain edema in the gerbil was achieved with ginkgolide B , and the compound re duced the accumulation of free fatty acids in the postischemic gerbil brain (Panetta et al., 1987) . However, it has not yet been shown that neuronal cells are actually protected against ischemic dam age by this PAF antagonist. In the present investi gation we tried to evaluate if ginkgolide B could prevent the selective neuronal death in the hippo campus of rats subjected to transient forebrain isch emia. This delayed neuronal death has been ob served in rats (Pulsinelli et al., 1982) as well as in gerbils (Kirino, 1982) .
MATERIALS AND METHODS
Male Wistar rats (Ivanovas, Kisslegg, F.R. G. ) weigh ing 220-310 g were used in the experiments. The animals were kept under standard conditions and fed a standard ginkgolide B (50 mg/kg p. o.) significantly reduced neuro nal damage. It is suggested that the antagonism of PAF is responsible for this beneficial effect of ginkgolide B. Key Words: Delayed neuronal death-Ginkgolide B Ischemia-Rat hippocampus. diet (Altromin, Lage, F.R.G.) and tap water ad libitum. The rats were fasted overnight before surgical treatment.
Ginkgolide B was a gift from Schwabe (Karlsruhe, F.R.G.). All other chemicals were of reagent grade.
Arterial Pco2, Po2, pH (Corning 178, Corning Medical, Giefien, F.R.G.), blood pressure (Statham P23Db, Heto Rey, Puerto Rico; HSE-Elektromanometer, Hugstetten, F.R.G.), and plasma glucose (Glucose Analyzer II; Beck man, Munich, F.R.G.) were checked routinely.
Surgery and induction of ischemia were performed ac cording to Smith et al. (1984) . Briefly, the rats were ven tilated artificially with a mixture of 30% O2 in N20 by means of a Starling-type respirator. Under halothane an esthesia (0.8%), the tail artery and jugular vein were can nulated for blood sampling, blood pressure recording, and central venous exsanguination, respectively. Needle elec trodes were placed into the temporalis muscle for EEG recording during ischemia. Heparin was injected intrave nously (200 IU/kg) and halothane was discontinued. Mus cle paralysis was maintained with 5 mg/kg suxametho nium chloride every 15-20 min. Thirty minutes after dis continuation of halothane, trimethaphan camphor sulfonate (5 mg/kg; Hoffmann-La Roche, Grenzach Wyhlen, F.R. G.) was infused and ischemia was induced by clamping of the exposed carotids and exsanguination to a blood pressure of 40 mm Hg. Onset of isoelectric EEG was taken as indicator for ischemia. After 10 min, ischemia was terminated by removal of the carotid clamps and rapid reinfusion of the shed blood. The rats then received NaHC03 (1 mmol/kg). The body tempera ture was maintained at 37°C throughout the whole proce dure.
After 7 days of recovery, the rats were anesthetized with nitrous oxide and halothane and the brains were per-fusion-fixed transcardially via the ascending aorta with 4% buffered formaldehyde. The brains were postfixed for 24 h in the perfusion medium, dehydrated, embedded in Paraplast (Monoject Scientific, Kildare, Ireland), and sectioned in 5-ILm slices. The slices were stained for ac idophilic necrotic cells with a mixture of 1 % celestine blue and 1 % acid fuchsin. Intact and necrotic cells of the hippocampus were counted in five consecutive, equidis tant planes 6 mm rostral to the tentorial incision.
Ginkgolide B (50 mg/kg) could not be dissolved in any well-tolerated vehicle and therefore was suspended in neutral oil. It was given per os 1 h prior to ischemia. The untreated controls received neutral oil per os.
Statistical evaluation was done with the Mann-Whitney U test.
RESULTS
Ginkgolide B did not influence physiological pa rameters as measured � 1 h after administration (Table 1) , nor did it change the weight loss of the animals during the 7-day recovery (not shown). The number of necrotic cells in the CAl region of hip pocampus was significantly reduced by ginkgolide B in comparison with the untreated controls. In ar eas CA3 and CA4, the extent of cell necrosis was low and was not influenced by ginkgolide B treat ment (Fig. 1) .
DISCUSSION
Ginkgolide B has been identified as a potent an tagonist of P AF (Braquet et aI. , 1985) . As reviewed by Braquet et ai. (1989) , PAF is involved in several events conceivably leading to damage of ischemic tissue. Therefore, antagonists of this compound have been tested for protective effects against isch emic pathologies.
PAF antagonists have been shown to reduce postischemic brain damage as evaluated by neuro logical, biochemical, and electrophysiological pa rameters in gerbils and dogs (reviewed by Braquet et aI., 1989) . However, it has not been shown that Values are means ± SD of n experiments. Ginkgolide B was given perorally 60 min prior to ischemia; untreated controls re ceived neutral oil per os. Physiologic variables were determined a few minutes before induction of ischemia. the morphological integrity of neurons can be pre served by treatment with a P AF antagonist. The transient forebrain ischemia according to Smith et ai. (1984) was particularly well suited for these ex periments, because neuronal cell damage is pro duced very selectively and reliably and protective drug effects are easily evaluated. Ginkgolide B could not be dissolved in the vehicle. Furthermore, the compound is chemically labile (H. Jaggy, per sonal communication), and poor bioavailability was anticipated. Therefore, we chose the rather high dose of 50 mg/kg. We achieved a quite effective protection of hip pocampal cells by ginkgolide B. Thus, we, for the first time, could provide histological evidence for the protective effect of PAF antagonists on neurons subjected to an ischemic challenge. Our results add significant information to previous reports about ce rebral protection by PAF antagonists given either pre-or postischemically (Panetta et aI., 1987; Spin newyn et aI., 1987; Bielenberg and Wagener, 1989; Braquet et al. , 1989) . They thus confirm the sugges tion that PAF is crucially involved in the postisch emic impairment of neuronal structure and func tion. Further experiments shall clarify if ginkgolide B can also exert its beneficial action after postisch emic administration, since this would be even more relevant for therapeutic considerations.
In conclusion, ginkgolide B has been shown to be effective against the postischemic neuronal damage in rat hippocampus. This effect is suggested to be a result of the P AF -antagonistic properties of this compound.
